Abstract:Despite bariatric surgery's success for most patients, up to 30 % do not experience optimal weight loss outcomes. Post-surgery weight loss outcomes are influenced by a complex interplay of factors that remain incompletely understood. Novel hypotheses are needed to identify putative predictors of suboptimal post-bariatric weight loss. Thyroid hormones, due to their important role in energy expenditure, have received study though research to date has not established clear associations between post-surgical weight loss and changes in standard thyroid markers. In contrast, research consistently documents a pattern similar to euthyroid sick syndrome (ESS) during severe caloric deprivation or fasting. ESS, an established response to periods of stress (e.g., critical illness, infection, famine) is believed to serve a protective function by suppressing metabolism and conserving weight. Defining features of ESS are: 1) TSH levels within normal range; 2) abnormally low levels of the metabolically active form of thyroid hormone, or free triiodothyronine (FT 3 ); 3) abnormally high levels of the metabolically inactive reverse 3,3′,5′-triiodothyronine (rT 3 ); and 4) abnormally low ratios of FT 3 to rT 3 . Low FT 3 /rT 3 ratio levels significantly predict survival outcomes in ESS. We present the novel hypothesis that: 1) severe hypocaloric dieting during the early post-surgical period may trigger an ESS-like syndrome; 2) development of ESS will be signaled by a decrease in the FT 3 /rT 3 ratio; and 3) early decreases in the FT 3 /rT 3 ratio will be associated with reduced weight loss at standard 1- and 2-year post-surgical follow-up visits. To examine whether preliminary data might support our hypothesis, we undertook a small exploratory study by collecting TSH, FT 4 , FT 3 , rT 3 , and hypothyroid symptoms from adult patients undergoing Roux-en-Y gastric bypass (n = 12) or sleeve gastrectomy (n = 11). Body mass index was measured pre-surgery and 1- and 2-years post-surgery. Results showed reductions in the FT 3 :rT 3 ratio from pre- to early post-surgery significantly predicted reduced weight loss at 1 (p = 0.03) and 2 years (p = 0.02) post-surgery. No other thyroid-related markers nor symptoms were predictive. Replication with larger samples is needed, especially given our sizeable attrition at 1- and 2-year follow-up. In conclusion, our hypothesis that markers of ESS during the early post-surgical period would predict reduced longer-term weight loss was supported. If replicated in future, larger investigations, a practical application of this hypothesis-generating paper involves using the FT 3 :rT 3 ratio to identify post-bariatric patients at risk for longer-term suboptimal weight loss, potentially opening a key therapeutic window for therapeutic intervention (e.g., T 3 repletion).

Changes in thyroid hormones predict weight regain in patients with obesity who undergo metabolic surgery

Total weight loss induces the alteration in thyroid function after bariatric surgery

Preoperative Thyroid Autoimmune Status and Changes in Thyroid Function and Body Weight after Bariatric Surgery.

Thyroid-stimulating hormone levels in euthyroid patients 8 years following bariatric surgery

Alterations in Thyroid Hormones in Obese Patients are Associated with Body Composition Changes after Bariatric Surgery

Thyroid Function Before and After Laparoscopic Sleeve Gastrectomy in Patients with Obesity

Metabolic surgery results in greater metabolic benefits in patients who achieve healthy weight

Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Patients with Morbid Obesity and Normal Thyroid Function

Do early indicators of euthyroid sick syndrome predict later post-bariatric weight loss? Exploring a novel hypothesis

Correlation Between Impaired Sensitivity to Thyroid Hormones and Serum Uric Acid in Female Patients with Obesity and After Laparoscopic Sleeve Gastrectomy

Weight loss and subclinical hypothyroidism in obese patients with sleeve gastrectomy

Significant dysregulation of lipid metabolism in patients with papillary thyroid carcinoma after thyroidectomy

Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study

Relationship of Vitamin A and Thyroid Function in Individuals With Obesity and After Laparoscopic Sleeve Gastrectomy

Thyroid function before and after Roux-en-Y gastric bypass: an observational study

Changes in Urinary Iodine Levels Following Bariatric Surgery

Correlation of T2DM and Anthropometric Measures with Total Small Bowel Length and Its Effects on Diabetes Remission After Bariatric Surgery

Changes in adipokine levels and metabolic profiles following bariatric surgery

Outcome of bariatric surgery on hypothyroidism: experience from a tertiary care center in India

Clinical Impact of Obesity on Postoperative Outcomes of Patients With Thyroid Cancer Undergoing Thyroidectomy: A 5‐Year Retrospective Analysis From the US National Inpatient Sample

Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery